top of page

The ACT-Accelerator Facilitation Council provides high-level advice, guidance and leadership to facilitate the work of the ACT-Accelerator 

The Facilitation Council is currently on standby and has been replaced by a new Tracking & Monitoring Taskforce



28 Oct 2022


11 May 2021


7 Jul 2022


4 Feb 2021


25 Apr 2022


8 Feb 2021


27 Feb 2022


13 Dec 2020


8 Dec 2021


2 Nov 2020


14 Oct 2021


9 Sept 2020

Colombia_house to house.jpeg

Working Groups

Set up to structure and drive the Facilitation Council's work to provide high-level political leadership and enabling advice on global advocacy and resource mobilisation. 

Facilitation Council

Tracking and Accelerating Progress

Promoting the achievement of global targets for vaccines, diagnostics, therapeutics, and PPE.

Terms of reference

Latest updates on our Impact page

Working Group Reports:

30 May 22- Update on Monitoring Vaccination, Testing, Treatment & PPE Targets for COVID-19 


Supporting the call for higher income countries to contribute their 'fair share' of the ACT-Accelerator's funding needs 

Terms of reference


Working Group Reports:

ACT-Accelerator Financing Framework

Financial and Resource Mobilisation

Diagnostics and Therapeutics 


Assessing current and future barriers to production, demand and accessibility to COVID-19 Therapeutics and Diagnostics, and provide recommendations to address these barriers.

Terms of reference

Working Group Reports:

22 Sept 22 - ACT-Accelerator Facilitation Council Working Group Report on Diagnostics and Therapeutics


Focus on the actions needed to enhance supply of vaccines through COVAX, from supply chain issues to unleashing capacities in developing countries where there is no or limited production capacity. Co-Chairs: South Africa and Germany

Terms of reference

(Ended last 2021 after submission of report to the G20)

ACT-A Evaluation

The ACT-Accelerator Facilitation Council commissioned an independent evaluation of ACT-A and its activities, identifying lessons learnt that will be of use in establishing a future global pandemic preparedness response to enhance global health security.

It was published in October 2022. For more information, please visit the Evaluation page

bottom of page